CPT code 86829: HLA antibodies, class I or II, qualitative2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Qualitative testing reports whether antibodies to HLA Class I or Class II are present when a single-class HLA antibody assessment is performed.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide

Medicare pays $64.19 for 86829 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$64.19

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 86829 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 86829 covers

This laboratory test uses a solid-phase assay to assess whether antibodies to HLA Class I or Class II are present. Methods may include microsphere or bead assays, ELISA, or flow cytometry. Report 86829 for a qualitative assessment of one HLA class; its result is presence or absence rather than a semiquantitative panel result. HLA phenotype testing is a different service, as it evaluates HLA class phenotype rather than antibodies.

Medicare pays 86829 through the Clinical Laboratory Fee Schedule (CLFS), at one national amount per code across states and localities, without an office or facility adjustment. The 2026 national CLFS amount is $64.19, unchanged since 2020. The code is paid only through the CLFS and has no physician fee schedule payment.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 86829

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 86829. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 86829 with status X (excluded by statute), so the test itself is paid only from the CLFS.

86829 on the lab fee schedule since 2020

86829 · CLFS 2026 Q4 (current)

$64.19

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

86829 compared with similar tests

86828HLA antibodiesBoth HLA classes$64.19
86829 assesses antibodies to Class I or Class II alone; 86828 covers both classes in the qualitative assessment.
86832HLA antibody panelClass I, high-definition qualitative$323.75
86832 is the high-definition qualitative assessment for Class I antibodies. 86829 is the qualitative assessment for one HLA class.
86834HLA antibody panelClass I, semiquantitative$357.56
86834 reports a semiquantitative panel assessment of Class I antibodies. 86829 reports antibody presence or absence for one HLA class.

86829 billing questions

When should 86829 be selected instead of 86828?

Use 86829 when the qualitative antibody assessment is for Class I or Class II alone. Use 86828 when both classes are assessed together.

What result does 86829 report?

It reports whether antibodies to the selected HLA class are present or absent. Semiquantitative panel testing is reported with a different code.

Is 86829 an HLA typing or phenotype test?

No. It assesses antibodies directed against HLA antigens, while phenotype testing assesses the patient's HLA characteristics.

How does Medicare pay for 86829?

Medicare pays the laboratory test through the CLFS at one national amount, with no locality or office-versus-facility adjustment. It is paid only through the CLFS.

Is a physician interpretation separately paid under 86829?

The code is paid only through the CLFS; it has no separate physician fee schedule payment.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 86829PUF_CLFS_CY2026_Q4V1.csv, line 1,840 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 86829?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 86829 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist